E. Solà

P. Angeli, P. Ginès, Javier Fernández, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.

W. Jiménez, M. Morales-Ruiz, V. Arroyo, 2014, Journal of hepatology.

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes

M. Morales-Ruiz, P. Sancho-Bru, P. Ginès, 2017, Scientific Reports.

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

B. Colsch, C. Junot, F. Nevens, 2019, Journal of hepatology.

Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.

P. Angeli, P. Ginès, A. Cárdenas, 2017, The American journal of medicine.

Are We Ready to Evaluate Adrenal Function in Patients With Decompensated Cirrhosis and Acute on Chronic Liver Failure?

P. Ginès, E. Solà, C. Solé, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

M. Pavesi, V. Arroyo, R. Hernaez, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis.

E. Poch, P. Ginès, Javier Fernández, 2013, Journal of hepatology.

CD38 contributes to human natural killer cell responses through a role in immune synapse formation

Mark M. Davis, Mathieu Le Gars, S. Shen-Orr, 2018 .

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival

J. Farrés, W. Jiménez, M. Morales-Ruiz, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome

F. Nevens, J. Trebicka, A. Gerbes, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be".

E. Poch, P. Ginès, Javier Fernández, 2015, Journal of hepatology.

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

M. Pavesi, V. Arroyo, F. Saliba, 2014, Critical Care.

Long Term Sorafenib Response for ExtramedullaryFLT3+AML Relapse after Allogeneic Stem CellTransplantation

Á. Figuera, A. Alegre, E. Solà, 2020 .

Editorial: macrophage activation markers predict prognosis and decompensation in patients with cirrhosis—linking gut permeability, inflammation and cirrhosis progression

E. Pose, E. Solà, C. Solé, 2018, Alimentary pharmacology & therapeutics.

Reply to: "To close the stable door before the horse has bolted".

P. Ginès, C. Elia, E. Solà, 2014, Journal of hepatology.

Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites

M. Morales-Ruiz, J. García-Valdecasas, J. Balust, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome

P. Kamath, M. Morales-Ruiz, P. Ginès, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

V. Arroyo, P. Ginès, M. Guevara, 2010, Hepatology.

Prevalence and Short-term Mortality of Acuteon-Chronic Liver Failure (ACLF) in the Veterans Affairs Hospitals (2004-2014): a National US Cohort.

H. El‐Serag, R. Moreau, A. Gerbes, 2017 .

Current treatment strategies for hepatorenal syndrome

P. Ginès, M. Guevara, E. Solà, 2013, Clinical liver disease.

Results of pretransplant treatment of hepatorenal syndrome with terlipressin

P. Ginès, A. Cárdenas, E. Solà, 2013, Current opinion in organ transplantation.

Chronic Kidney Disease in Cirrhosis: Emerging Complication With Negative Impact in the Liver Transplant Setting

P. Ginès, E. Solà, P. Ginés, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

1365 ACUTE KIDNEY INJURY NETWORK (AKIN) CRITERIA FOR ACUTE RENAL FAILURE PREDICTS OUTCOME IN HOSPITALIZED CIRRHOTIC PATIENTS. A PROSPECTIVE STUDY

M. Pavesi, V. Arroyo, P. Ginès, 2011 .

844 COMPARISON OF AKIN CRITERIA AND CONVENTIONAL CRITERIA FOR DEFINITION OF RENAL IMPAIRMENT IN CIRRHOSIS. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY

V. Arroyo, P. Ginès, M. Guevara, 2010 .

ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM.

G. Nicolao, A. Forner, P. Kamath, 2020, Journal of hepatology.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

R. Bataller, J. Muntané, F. Jorquera, 2018 .

Acute-on-chronic liver failure: an update

R. Moreau, R. Hernaez, P. Ginès, 2017, Gut.

Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions

Mark M. Davis, A. Christophersen, K. Lundin, 2019, Nature Medicine.

The role of antigen recognition in the γδ T cell response at the controlled stage of M. tuberculosis infection

Mark M. Davis, Y. Chien, P. Nguyen, 2021, bioRxiv.

Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension

M. Pavesi, V. Arroyo, P. Ginès, 2010, Hepatology.

ALTERATIONS IN GUT MICROBIOME IN CIRRHOSIS AS ASSESSED BY QUANTITATIVE METAGENOMICS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE AND PROGNOSIS.

N. Borruel, F. Casellas, J. Doré, 2020, Gastroenterology.

Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.

H. El‐Serag, R. Moreau, A. Gerbes, 2019, Journal of hepatology.

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis

R. Hernaez, P. Ginès, A. Cárdenas, 2021, Gut.

Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis

S. Kalko, W. Jiménez, M. Morales-Ruiz, 2016, Scientific Reports.

Prognostic importance of the cause of renal failure in patients with cirrhosis.

M. Pavesi, V. Arroyo, J. Rodés, 2011, Gastroenterology.

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis

Mark M. Davis, P. Kamath, J. Trebicka, 2021, Hepatology communications.

Response to nosocomial spontaneous bacterial peritonitis: discussing a specific infection treatment algorithm

P. Ginès, E. Solà, C. Solé, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

W. Jiménez, M. Morales-Ruiz, P. Ginès, 2021, Journal of hepatology.

Hyponatremia in Cirrhosis: Evaluation and Treatment

P. Ginès, A. Cárdenas, E. Solà, 2013 .

Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.

P. Ginès, E. Solà, P. Ginés, 2010, Journal of hepatology.

Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.

M. Pavesi, V. Arroyo, P. Ginès, 2012, Journal of hepatology.

Importance of the Cause of Renal Failure in Patients ith Cirrhosis

M. Pavesi, V. Arroyo, J. Rodés, 2022 .

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.

F. Nevens, R. Moreau, R. Jalan, 2016, Journal of hepatology.

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

M. Pavesi, V. Arroyo, L. Moreira, 2012, Hepatology.

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.

H. Verspaget, R. Jalan, F. Durand, 2016, Journal of hepatology.

Clinical Application of Kidney Biomarkers in Cirrhosis.

P. Ginès, A. Allegretti, E. Solà, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis

A. Gerbes, M. Pavesi, V. Arroyo, 2014, Gut.

Assessment of renal function in cirrhosis: Sarcopenia, gender and ethnicity matter.

C. Francoz, E. Solà, 2019, Journal of hepatology.

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure

J. Trebicka, J. Lozano, R. Schierwagen, 2021, JHEP reports : innovation in hepatology.

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival

H. Verspaget, R. Jalan, F. Durand, 2017, Critical Care.

Neutrophil Gelatinase‐Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study

W. Jiménez, M. Morales-Ruiz, E. Poch, 2019, Hepatology.

Hepatorenal syndrome

P. Kamath, P. Angeli, F. Wong, 2018, Nature Reviews Disease Primers.

Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.

M. Poca, A. Andrealli, V. Arroyo, 2014, Journal of hepatology.

Non-invasive criteria for diagnosis of alcoholic hepatitis: use in clinical practice and correlation with prognosis

E. Pose, I. Graupera, N. Fabrellas, 2020, Journal of Hepatology.

Type‐1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival

V. Arroyo, J. Rodés, Javier Fernández, 2014, Hepatology.

Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study.

V. Arroyo, E. Poch, Javier Fernández, 2015, Journal of hepatology.

Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project

P. Kamath, J. Trebicka, F. Durand, 2020, Hepatology.

Cell death markers in patients with cirrhosis and acute decompensation

R. Moreau, R. Jalan, A. Gerbes, 2017, Hepatology.

Cell death markers in cirrhotic patients with acute decompensation

R. Moreau, R. Jalan, A. Gerbes, 2017 .

Evaluation and treatment of the critically ill cirrhotic patient

J. Genescà, Javier Fernández, G. Soriano, 2016 .

[Evaluation and treatment of the critically ill cirrhotic patient].

J. Genescà, Javier Fernández, G. Soriano, 2016, Gastroenterologia y hepatologia.

Assessment of acute kidney injury at hospital admission in cirrhosis: estimating baseline serum creatinine is not the answer

E. Solà, P. Ginés, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis

W. Jiménez, M. Morales-Ruiz, V. Arroyo, 2015, PloS one.

P937 EARLY TREATMENT WITH TERLIPRESSIN AND ALBUMIN IS EFFECTIVE FOR TYPE-1 HEPATORENAL SYNDROME ASSOCIATED WITH SEPSIS

M. Poca, A. Andrealli, V. Arroyo, 2014 .

DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY IN PATIENTS WITH CIRRHOSIS IS COMMON AND IMPAIRS CLINICAL OUTCOMES.

E. Poch, S. Albertos, Javier Fernández, 2020, Journal of hepatology.

Hepatorenal syndrome in the era of acute kidney injury

E. Pose, E. Solà, C. Solé, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Pro: Acute‐on‐chronic liver failure

E. Solà, P. Ginés, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Acute-on-Chronic Liver Failure: The Role of Precipitating Illness

Javier Fernández, E. Solà, P. Ginés, 2016, Seminars in Liver Disease.

Reply to: "Are we still searching for the fifth element of MELD?"

M. Coenraad, E. Solà, A. Kerbert, 2017, Journal of hepatology.

O09 A double blind, randomised, placebo-controlled study to assess safety and tolerability of oral enterosorbent Carbalive (Yaq-001) in cirrhotic patients

Mar Hernández Obiols, S. Eaton, K. Church, 2021, Oral.

Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions

Mark M. Davis, A. Christophersen, K. Lundin, 2019, Nature Medicine.

Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute‐on‐chronic liver failure and acute decompensation

H. Møller, R. Jalan, S. Zeuzem, 2020, Journal of gastroenterology and hepatology.

P1316 : Effects of long-term administration of midodrine and albumin in the prevention of complications in patients with cirrhosis on waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial. macht study

P. Suñé, V. Arroyo, J. Castellote, 2015 .

Midodrine and albumin for prevention of complications of cirrhosis in patients in the waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial

P. Suñé, M. Pavesi, J. Castellote, 2017 .

Update on acute-on-chronic liver failure.

E. Solà, C. Solé, 2018, Gastroenterologia y hepatologia.

NK-like CD8+ γδ T cells are expanded in persistent Mycobacterium tuberculosis infection

Y. Chien, J. Wilhelmy, T. Scriba, 2023, Science Immunology.

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life

F. Torres, E. Pose, I. Graupera, 2022, PloS one.

Characterization of systemic inflammatory response in hepatorenal syndrome in cirrhosis. A major role for il-6, TNF-alpha, and VCAM

W. Jiménez, M. Morales-Ruiz, E. Pose, 2018 .

Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes

M. Navasa, V. Arroyo, Javier Fernández, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica

J. Muntané, F. Jorquera, M. Diago, 2018 .

Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica

J. Muntané, F. Jorquera, M. Diago, 2018 .

Assessment of kidney function in cirrhosis: Are we moving closer to accurate estimation of glomerular filtration rate?

A. Ma, E. Solà, A. Juanola, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Reply to: "Transition of AKI to CKD in cirrhosis - effect of baseline eGFR and unanswered questions".

E. Solà, Octavi Bassegoda, P. Ginés, 2020, Journal of hepatology.

Lack of evidence for a continuum between hepatorenal syndrome and acute tubular necrosis.

P. Kamath, E. Solà, C. Solé, 2019, Journal of hepatology.

M. Pavesi, V. Arroyo, M. Guevara, 2012, Journal of hepatology.

Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be".

E. Poch, Javier Fernández, I. Graupera, 2015, Journal of hepatology.

Management of uninfected and infected ascites in cirrhosis

E. Solà, C. Solé, P. Ginés, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

P. Suñé, M. Pavesi, M. Navasa, 2018, Journal of hepatology.

Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease.

M. Navasa, J. Fuster, V. Arroyo, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evaluation and treatment of the critically ill cirrhotic patient

J. Genescà, Javier Fernández, G. Soriano, 2019 .

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

S. Moestrup, H. Møller, V. Arroyo, 2016, Journal of hepatology.